394 related articles for article (PubMed ID: 26510990)
1. Longitudinal immune profiles in type 1 leprosy reactions in Bangladesh, Brazil, Ethiopia and Nepal.
Khadge S; Banu S; Bobosha K; van der Ploeg-van Schip JJ; Goulart IM; Thapa P; Kunwar CB; van Meijgaarden KE; van den Eeden SJ; Wilson L; Kabir S; Dey H; Goulart LR; Lobato J; Carvalho W; Bekele Y; Franken KL; Aseffa A; Spencer JS; Oskam L; Otttenhoff TH; Hagge DA; Geluk A
BMC Infect Dis; 2015 Oct; 15():477. PubMed ID: 26510990
[TBL] [Abstract][Full Text] [Related]
2. New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy.
Geluk A; Bobosha K; van der Ploeg-van Schip JJ; Spencer JS; Banu S; Martins MV; Cho SN; Franken KL; Kim HJ; Bekele Y; Uddin MK; Hadi SA; Aseffa A; Pessolani MC; Pereira GM; Dockrell HM; Ottenhoff TH
J Immunol; 2012 May; 188(10):4782-91. PubMed ID: 22504648
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium leprae virulence-associated peptides are indicators of exposure to M. leprae in Brazil, Ethiopia and Nepal.
Bobosha K; Tang ST; van der Ploeg-van Schip JJ; Bekele Y; Martins MV; Lund O; Franken KL; Khadge S; Pontes MA; Gonçalves Hde S; Hussien J; Thapa P; Kunwar CB; Hagge DA; Aseffa A; Pessolani MC; Pereira GM; Ottenhoff TH; Geluk A
Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():112-23. PubMed ID: 23283462
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal immune responses and gene expression profiles in type 1 leprosy reactions.
Geluk A; van Meijgaarden KE; Wilson L; Bobosha K; van der Ploeg-van Schip JJ; van den Eeden SJ; Quinten E; Dijkman K; Franken KL; Haisma EM; Haks MC; van Hees CL; Ottenhoff TH
J Clin Immunol; 2014 Feb; 34(2):245-55. PubMed ID: 24370984
[TBL] [Abstract][Full Text] [Related]
5. From genome-based in silico predictions to ex vivo verification of leprosy diagnosis.
Geluk A; Spencer JS; Bobosha K; Pessolani MC; Pereira GM; Banu S; Honoré N; Reece ST; MacDonald M; Sapkota BR; Ranjit C; Franken KL; Zewdie M; Aseffa A; Hussain R; Stefani MM; Cho SN; Oskam L; Brennan PJ; Dockrell HM;
Clin Vaccine Immunol; 2009 Mar; 16(3):352-9. PubMed ID: 19176694
[TBL] [Abstract][Full Text] [Related]
6. Whole blood RNA signatures in leprosy patients identify reversal reactions before clinical onset: a prospective, multicenter study.
Tió-Coma M; van Hooij A; Bobosha K; van der Ploeg-van Schip JJ; Banu S; Khadge S; Thapa P; Kunwar CB; Goulart IM; Bekele Y; Hagge DA; Moraes MO; Teles RMB; Pinheiro RO; van Zwet EW; Goeman JJ; Aseffa A; Haks MC; Ottenhoff THM; Modlin RL; Geluk A
Sci Rep; 2019 Nov; 9(1):17931. PubMed ID: 31784594
[TBL] [Abstract][Full Text] [Related]
7. Complement activation in leprosy: a retrospective study shows elevated circulating terminal complement complex in reactional leprosy.
Bahia El Idrissi N; Hakobyan S; Ramaglia V; Geluk A; Morgan BP; Das PK; Baas F
Clin Exp Immunol; 2016 Jun; 184(3):338-46. PubMed ID: 26749503
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Immunodiagnostic Tests for Leprosy in Brazil, China and Ethiopia.
van Hooij A; Tjon Kon Fat EM; Batista da Silva M; Carvalho Bouth R; Cunha Messias AC; Gobbo AR; Lema T; Bobosha K; Li J; Weng X; Salgado CG; Spencer JS; Corstjens PLAM; Geluk A
Sci Rep; 2018 Dec; 8(1):17920. PubMed ID: 30560920
[TBL] [Abstract][Full Text] [Related]
9. Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays.
Geluk A; van der Ploeg-van Schip JJ; van Meijgaarden KE; Commandeur S; Drijfhout JW; Benckhuijsen WE; Franken KL; Naafs B; Ottenhoff TH
Clin Vaccine Immunol; 2010 Jun; 17(6):993-1004. PubMed ID: 20427628
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa.
Bobosha K; Van Der Ploeg-Van Schip JJ; Zewdie M; Sapkota BR; Hagge DA; Franken KL; Inbiale W; Aseffa A; Ottenhoff TH; Geluk A
Lepr Rev; 2011 Dec; 82(4):445-58. PubMed ID: 22439283
[TBL] [Abstract][Full Text] [Related]
11. Correlates of immune exacerbations in leprosy.
Geluk A
Semin Immunol; 2018 Oct; 39():111-118. PubMed ID: 29950273
[TBL] [Abstract][Full Text] [Related]
12. Field-evaluation of a new lateral flow assay for detection of cellular and humoral immunity against Mycobacterium leprae.
Bobosha K; Tjon Kon Fat EM; van den Eeden SJ; Bekele Y; van der Ploeg-van Schip JJ; de Dood CJ; Dijkman K; Franken KL; Wilson L; Aseffa A; Spencer JS; Ottenhoff TH; Corstjens PL; Geluk A
PLoS Negl Trop Dis; 2014 May; 8(5):e2845. PubMed ID: 24810599
[TBL] [Abstract][Full Text] [Related]
13. Fingerstick test quantifying humoral and cellular biomarkers indicative for M. leprae infection.
Corstjens PLAM; van Hooij A; Tjon Kon Fat EM; Alam K; Vrolijk LB; Dlamini S; da Silva MB; Spencer JS; Salgado CG; Richardus JH; van Hees CLM; Geluk A
Clin Biochem; 2019 Apr; 66():76-82. PubMed ID: 30695682
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of interferon-gamma, tumour necrosis factor-alpha, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions.
Iyer A; Hatta M; Usman R; Luiten S; Oskam L; Faber W; Geluk A; Das P
Clin Exp Immunol; 2007 Nov; 150(2):210-6. PubMed ID: 17937676
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.
Richardus RA; van der Zwet K; van Hooij A; Wilson L; Oskam L; Faber R; van den Eeden SJF; Pahan D; Alam K; Richardus JH; Geluk A
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006083. PubMed ID: 29228004
[TBL] [Abstract][Full Text] [Related]
16. Exploratory urinary metabolomics of type 1 leprosy reactions.
Mayboroda OA; van Hooij A; Derks R; van den Eeden SJ; Dijkman K; Khadge S; Thapa P; Kunwar CB; Hagge DA; Geluk A
Int J Infect Dis; 2016 Apr; 45():46-52. PubMed ID: 26923082
[TBL] [Abstract][Full Text] [Related]
17. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
18. The immunobiology of leprosy.
Kaplan G; Cohn ZA
Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911
[TBL] [Abstract][Full Text] [Related]
19. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
20. Changes in cellular response to mycobacterial antigens and cytokine production patterns in leprosy patients during multiple drug therapy.
Trao VT; Huong PL; Thuan AT; Anh DD; Trach DD; Rook GA; Wright EP
Immunology; 1998 Jun; 94(2):197-206. PubMed ID: 9741341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
